Advertisement

Potential Regulators of Physiological Cell Death in the Corpus Luteum

  • Bo R. Rueda
  • Debora L. Hamernik
  • Patricia B. Hoyer
  • Jonathan L. Tilly
Part of the Proceedings in the Serono Symposia USA Series book series (SERONOSYMP)

Abstract

The corpus luteum (CL) is formed within the mammalian ovary from the remaining follicular tissue following ovulation of the dominant follicle(s). The primary function of the CL is to synthesize and secrete progesterone. Circulating levels of progesterone rise during luteinization of the ovulated follicle and are maintained in order to provide uterine quiescence for the establishment and maintenance of pregnancy. If, however, fertilization fails or does not occur, the CL regresses by a process referred to as luteolysis. The CL, like most female reproductive endocrine tissues, goes through a phase of rapid cellular growth, proliferation and neovascularization that, by many criteria, is analogous to tumor development. Unlike a tumor, however, the lifespan of the luteal cells is defined as removal of the CL is important for resumption of the next estrous or menstrual cycle. As would be expected, luteal regression is likely mediated via apoptosis. Although much is known about CL function, relatively little is known about mechanisms that regulate luteal cell death. Recently, there has been a plethora of information published regarding the role of reactive oxygen species (ROS), protooncogenes, tumor suppressor genes, transcription factors and proteases in regulating the fate of many cell types. The focus of this review is to discuss the potential role of oxidative stress response and cell death genes in regulating the lifespan of the CL. A brief review of the morphological and physiological aspects of luteal function and regression is also presented.

Keywords

Granulosa Cell Corpus Luteum Estrous Cycle Luteal Cell Luteal Tissue 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Farin CE, Moeller CL, Sawyer HR, Gamboni F, Niswender GD. Morphometric analysis of cell types in the ovine corpus luteum throughout the estrous cycle. Biol Reprod 1986; 35: 1299–1308.PubMedCrossRefGoogle Scholar
  2. 2.
    O’Shea JD, Rodgers RJ, Wright PJ. Cellular composition of the sheep corpus luteum in the mid-and late-luteal phases of the oestrous cycle. J Reprod Fertil 1986; 76: 685–91.PubMedCrossRefGoogle Scholar
  3. 3.
    O’Shea JD, Rodgers RJ, D’Occhio MJ. Cellular composition of the cyclic corpus luteum of the cow. J Reprod Fertil 1989; 85: 483–7.PubMedCrossRefGoogle Scholar
  4. 4.
    Ohara A, Mori T, Taii S, Ban C, Narimoto K. Functional differentiation in steroidogenesis of two types of luteal cells isolated from mature human corpora lutea of menstrual cycle. J Clin Endocr Met 1987; 65: 1192–1200.CrossRefGoogle Scholar
  5. 5.
    Lei ZM, Chegini N, Rao CV. Quantitative cell composition of human and bovine corpora lutea from various reproductive states. Biol Reprod 1991; 44: 1148–56.PubMedCrossRefGoogle Scholar
  6. 6.
    Retamales I, Carrasco I, Troncoso JL, Las Heras J, Devato L, Vega M. Morpho-functional study of human luteal cell subpopulations. Human Reprod 1994; 9: 591–6.Google Scholar
  7. 7.
    Hild-Petito S, Ottobre AC, Hoyer PB. Comparison of subpopulations of luteal cells obtained from cyclic and superovulated ewes. J Reprod Fertil 1987; 80: 537–44.PubMedCrossRefGoogle Scholar
  8. 8.
    Smith CJ, Greer TB, Banks TW, Sridaran R. The response of large and small luteal cells from the pregnant rat to substrates and secretagogues. Biol Reprod 1989; 41: 1123–32.PubMedCrossRefGoogle Scholar
  9. 9.
    Lemon M, Mauleon P. Interaction between two luteal cell types from the corpus luteum of the sow in progesterone synthesis in vitro. J Reprod Fertil 1982; 64: 31523.Google Scholar
  10. 10.
    Koos RD, Hansel W. The large and small cells of the bovine corpus luteum: ultra-structural and functional differences. In: Schwartz NB, Hunzicker-Dunn M eds. Dynamics of ovarian function. New York: Raven Press, 1982: 197–203.Google Scholar
  11. 11.
    O’Shea JD, Cran DG, Hay MF. The small luteal cell of the sheep. JAnat 1979; 128: 23951.Google Scholar
  12. 12.
    Rodgers RJ, O’Shea JD. Purification, morphology and progesterone production and content of three cell types isolated from the corpus luteum of the sheep. J Biol Sci 1982; 35: 441–55.Google Scholar
  13. 13.
    Fitz TA, Mayan HR, Sawyer HR, Niswender GD. Characterization of two steroidogenic cell types in the ovine corpus luteum. Biol Reprod 1982; 27: 703–11.PubMedCrossRefGoogle Scholar
  14. 14.
    Corner GW. On the origin of the corpus luteum of the sow from both granulosa and theca internal. Am J Anat 1919; 26: 117–83.CrossRefGoogle Scholar
  15. 15.
    McClellan MC, Diekman MA, Abel JH, Niswender GD. Luteinizing hormone, progesterone and the morphological development of normal and superovulated corpora lutea in sheep. Cell Tissue Res 1975; 164: 291–307.PubMedCrossRefGoogle Scholar
  16. 16.
    Wilkinson RF, Anderson G, Aalberg J. Cytological observations of dissociated rat corpus luteum. J Ultrastruct Res 1976; 57: 168–84.PubMedCrossRefGoogle Scholar
  17. 17.
    O’Shea JD, Cran DG, Hay MF. Fate of the theca interna following ovulation in the ewe. Cell Tissue Res 1980; 210: 305–19.PubMedGoogle Scholar
  18. 18.
    Chegini N. Ramani N, Rao CV. Morphological and biochemical characterization of small and large bovine luteal cells during pregnancy. Mol Cell Endocr 198437:89–102.Google Scholar
  19. 19.
    Fields MJ, Dubois W, Fields PA. Dynamic features of luteal secretory granules: ultrastructural changes during the course of pregnancy in the cow. Endocrinology 1985; 117: 1675–81.PubMedCrossRefGoogle Scholar
  20. 20.
    Rodgers RJ, O’Shea JD, Findlay JK. Do small and large luteal cells of the sheep interact in the production of progesterone? J Reprod Fertil 1985; 75: 85–94.PubMedCrossRefGoogle Scholar
  21. 21.
    Meyer GT, Bruce NW. The cellular pattern of corpus luteal growth during pregnancy in the rat. Anat Rec 1979; 193: 823–30.PubMedCrossRefGoogle Scholar
  22. 22.
    Sawyer HR, Niswender KD, Braden TD, Niswender GD. Nuclear changes in ovine luteal cells in response to PGF2a. DomAnim Endocrinol 1990; 7: 229–38.Google Scholar
  23. 23.
    Lobel BL, Levy E. Enzymatic correlates of development, secretory function and regression of follicles and corpora lutea in the bovine ovary. Acta Endocrinol Suppl 1968; 132: 5–63.Google Scholar
  24. 24.
    Bagavandoss P, Kunkel SL, Wiggins RC, Keyes PL. Tumor necrosis factor-a (TNFa) production and localization of macrophages and T-lymphocytes in the rabbit corpus luteum. Endocrinology 1988; 122: 1185–7.PubMedCrossRefGoogle Scholar
  25. 25.
    Brannstrom ?, Norman RJ. Involvement of leukocytes and cytokines in the ovula-tory process and corpus luteum function. Human Reprod 19938:1762–75.Google Scholar
  26. 26.
    Brannstrom M, Pascoe V, Norman RJ, McClure N. Localization of leukocyte subsets in the follicle wall and in the corpus luteum throughout the human menstrual cycle. Fertil Steril 1994; 61: 488–95.PubMedGoogle Scholar
  27. 27.
    Hoyer PB, Fitz TA, Niswender GD. Hormone-independent activation of adenylate cyclase in large steroidogenic ovine luteal cells does not result in increased progesterone secretion. Endocrinology 1984; 114: 604–8.PubMedCrossRefGoogle Scholar
  28. 28.
    Harrison LM, Kenny N, Niswender GD. Progesterone production: LH receptors and oxytocin secretion by ovine luteal cell types on days 6, 10 and 15 of the estrous cycle and day 25 of pregnancy. J Reprod Fertil 1987; 79: 539–48.PubMedCrossRefGoogle Scholar
  29. 29.
    Hoyer PB, Niswender GD. The regulation of steroidogenesis is different in the two types of ovine luteal cells. Can J Physiol Pharmacol 1985; 63: 240–8.PubMedCrossRefGoogle Scholar
  30. 30.
    Hoyer PB, Niswender GD. Adenosine 3’, 5’-monophosphate-binding capacity in small and large ovine luteal cells. Endocrinology 1986; 119: 1822–9.PubMedCrossRefGoogle Scholar
  31. 31.
    Pate JL, Nephew KP. Effects of in vivo and in vitro administration of prostaglandin F2a on lipoprotein utilization in cultured bovine luteal cells. Biol Reprod 1988; 38: 568–76.PubMedCrossRefGoogle Scholar
  32. 32.
    Hutchinson JS, Zeleznik AJ. The corpus luteum of the primate menstrual cycle is capable of recovering from a transient withdrawal of pituitary gonadotropin support. Endocrinology 1985; 117: 1043–9.CrossRefGoogle Scholar
  33. 33.
    Keyes PL, Possley RM, Yuh K-CM. Contrasting effects of oestradiol-l7ß and human chorionic gonadotropin on steroidogenesis in the rabbit corpus luteum. J Reprod Fertil 1983; 69: 579–86.PubMedCrossRefGoogle Scholar
  34. 34.
    Fraser HM, Nestor JJ, Vickery BH. Suppression of luteal function by a luteinizing hormone-releasing hormone antagonist during the early luteal phase in the stumptailed macaque monkey, and the effects of subsequent administration of human chorionic gonadotropin. Endocrinology 1987; 121: 612–8.PubMedCrossRefGoogle Scholar
  35. 35.
    McGuire WJ, Juengal JL, Niswender GD. Protein kinase C second messenger system mediates the antisteroidogenic effects of prostaglandin F2a in the ovine corpus luteum in vivo. Biol Reprod 1994; 51: 800–6.PubMedCrossRefGoogle Scholar
  36. 36.
    Hauger RL, Karsch FJ, Foster DL. A new concept for control of the estrous cycle of the ewe based on the temporal relationships between luteinizing hormone, estradiol and progesterone in peripheral serum and evidence that progesterone inhibits tonic LH secretion. Endocrinology 1977; 101: 807–17.PubMedCrossRefGoogle Scholar
  37. 37.
    McCracken JA, Glew ME, Scaramuzzi RJ. Corpus luteum regression induced by prostaglandins Fa2. J Clin Endocrinol Met 1970; 30: 544–6.Google Scholar
  38. 38.
    McCracken JA, Carlson JC, Glew ME, Goding JR, Baird DT, Green K, Samuelsson B. Prostaglandin F2a identified as a luteolytic hormone in sheep. Nature New Biol 1972; 83: 527–36.Google Scholar
  39. 39.
    Kimball FA, Lauderdale JW. Prostaglandin E1 and F2a1pha specific binding in bovine corpora lutea: comparison with luteolytic effects. Prostaglandins 1975; 10: 313–31.PubMedGoogle Scholar
  40. 40.
    Phariss BB, Wyngarden U. The effect of prostaglandin F2a on the progesterone content of ovaries from pseudopregnant rats. Proc Soc Exp Biol Med 1969; 130: 92–4.Google Scholar
  41. 41.
    Bennegard B, Hahlin M, Wennberg E, Noren H. Local luteolytic effect of prostaglandin F2alpha in the human corpus luteum. Fertil Stertil 1991; 56: 1070–6.Google Scholar
  42. 42.
    Gelety TJ, Chaudhuri G. Prostaglandins in the ovary and fallopian tube. Baillieres Clin Obstet Gynecol 1992; 6: 707–29.CrossRefGoogle Scholar
  43. 43.
    Pexton JE, Weems CW, Inskeep EK. Prostaglandin F in uterine venous plasma, ovarian arterial and venous plasma and in ovarian and luteal tissue of pregnant and non-pregnant ewes. J Anim Sci 1975; 41: 154–9.PubMedGoogle Scholar
  44. 44.
    Nett TM, Staigmiller RB, Akbar AM, Diekman NA, Ellinwood WE, Niswender GD. Secretion of prostaglandin F2a1pha in cycling and pregnant ewes. J Anim Sci 1976; 42: 876–80.PubMedGoogle Scholar
  45. 45.
    Lewis GS, Wilson L Jr, Wilks JW, Pexton JE, Fogwell RI, Ford SP, Butcher RL, Thayne WV, Inskeep EK. PGF2a and its metabolites in uterine and jugular venous plasma and endometrium of ewes during early pregnancy. J Anim Sci 1977; 45: 320–27.PubMedGoogle Scholar
  46. 46.
    Zarco L, Stabenfeldt GH, Basu S, Bradford GE, Kindahl H. Modification of prostaglandin F2a synthesis and release in the ewe during the initial establishment of pregnancy. J Reprod Fertil 1988; 83: 527–36.PubMedCrossRefGoogle Scholar
  47. 47.
    Nett TM, McClellan MC, Niswender GD. Effects of prostaglandins on the ovine corpus luteum: blood flow, secretion of progesterone and morphology. Biol Reprod 1976; 15: 66–78.PubMedCrossRefGoogle Scholar
  48. 48.
    Del Campo CH, Ginther OJ. Vascular anatomy of the uterus and ovaries and the unilateral luteolytic effect of the uterus: horses, sheep and swine. Am J Vet Res 1973; 34: 300–16.Google Scholar
  49. 49.
    Heap RB, Fleet IR, Hamon M. Prostaglandin F2aa is transferred from the uterus to the ovary in the sheep lymphatic and blood vascular pathways. J Reprod Fertil 1985; 74: 64556.Google Scholar
  50. 50.
    Michael AE, Abayasekara DRE, Webley GE. Cellular mechanisms of luteolysis. Mol Cell Endocr 1994; 99: R1–R9.CrossRefGoogle Scholar
  51. 51.
    Pate JL. Cellular components involved in luteolysis. J Anim Sci 1994; 72: 1884–90.PubMedGoogle Scholar
  52. 52.
    Keyes PL, Wiltbanlk MC. Endocrine regulation of the corpus luteum. Annu Rev Physiol 1988; 50: 465–82.PubMedCrossRefGoogle Scholar
  53. 53.
    Knickerbocker JJ, Wiltbank MC, Niswender GD. Mechanisms of luteolysis in domestic livestock. Dom Anim Endocrinol 1988; 5: 91–107.CrossRefGoogle Scholar
  54. 54.
    Wiltbank MC, Gallagher KP, Christensen AK, Brabec RK, Keyes PL. Physiological and immunological cytochemical evidence for a new concept of blood flow regulation in the corpus luteum. Biol Reprod 1990; 42: 139–49.PubMedCrossRefGoogle Scholar
  55. 55.
    Wiltbank MC. Cell types and hormonal mechanisms associated with mid-cycle corpus luteum function. J Anim Sci 1994; 72: 1873–83.PubMedGoogle Scholar
  56. 56.
    Balapure AK, Caicedo IC, Kawada K, Watt DS, Rexroad CE Jr, Fitz TA. Multiple classes of prostaglandin F2a binding sites in subpopulations of ovine luteal cells. Biol Reprod 1989; 41: 385–92.PubMedCrossRefGoogle Scholar
  57. 57.
    Wiepz GJ, Wiltbank MC, Nett TM, Niswender GD, Sawyer HR. Receptors for prostaglandins F2a and E2 in ovine corpora lutea during maternal recognition of pregnancy. Biol Reprod 1992; 47: 984–91.PubMedCrossRefGoogle Scholar
  58. 58.
    Powell WS, Hammarstrom S, Samuelsson B. Prostaglandin F2a receptor in ovine corpora lutea. Eur J Biochem 1974; 41: 103–7.PubMedCrossRefGoogle Scholar
  59. 59.
    Wiltbank MC, Guthrie PB, Mattson MP, Kater SB, Niswender GD. Hormonal regulation of free intracellular calcium concentrations in small and large ovine luteal cells. Biol Reprod 1989; 41: 771–78.PubMedCrossRefGoogle Scholar
  60. 60.
    Wegner JA, Martinez-Zaguilan R, Wise ME, Gillies RJ, Hoyer PB. Prostaglandin F2a-induced calcium transient in ovine large luteal cells: I. Alterations in cytosolic free calcium levels and calcium flux. Endocrinology 1990; 127: 3029–37.PubMedCrossRefGoogle Scholar
  61. 61.
    Wegner JA, Martinez-Zaguilan R, Gillies RJ, Hoyer PB. Prostaglandin F2a-induced calcium transient in ovine large cells: II. Modulation of the transient and resting cytosolic free calcium alters progesterone secretion. Endocrinology 1991; 128: 929–36.PubMedCrossRefGoogle Scholar
  62. 62.
    Geeraerts MD, Ronveaux-Dupal MF, Lemasters JJ, Herman B. Cytosolic free Ca2+ and proteolysis in lethal oxidative injury in endothelial cells. Am J Physiol 1991;261:?889–96.Google Scholar
  63. 63.
    Richter C, Kass GEN. Oxidative stress in mitochondria: its relationship to cellular Са2+ homeostasis, cell death, proliferation, and differentiation. Chem Biol Interactions 1991; 77: 1–23.CrossRefGoogle Scholar
  64. 64.
    Trump BF, Berezesky IK. The role of cytosolic Са2+in cell injury, necrosis and apoptosis. Cur Opinion Cell Biol 1992; 4: 227–32.CrossRefGoogle Scholar
  65. 65.
    Abdul-Karim RW, Bruce N. Blood flow to the ovary and corpus luteum at different stages of gestation in the rabbit. Fertil Steril 1973; 24: 44–47.PubMedGoogle Scholar
  66. 66.
    Wiltbank MC, Gallagher KP, Dysko RC, Keyes PL. Regulation of blood flow to the rabbit corpus luteum: effects of estradiol and human chorionic gonadotropin. Endocrinology 1989; 124: 605–11.PubMedCrossRefGoogle Scholar
  67. 67.
    Bruce NW, Meyer GT, Dharmarajan AM. Rate of blood flow and growth of the corpora lutea of pregnancy and of previous cycles throughout pregnancy in the rat. J Reprod Fertil 1984; 71: 445–52.PubMedCrossRefGoogle Scholar
  68. 68.
    Novy MJ, Cook MJ. Redistribution of blood flow by prostaglandin F2a in the rabbit ovary. Am J Obstet Gynecol 1973; 117: 381–5.PubMedGoogle Scholar
  69. 69.
    Nett TM, Niswender GD. Luteal blood flow and receptors for LH during PGF2a- induced luteolysis: production of PGE2 and PGF2aa during early pregnancy. Acta Vet Stand, Suppl 1981; 77: 117–30.Google Scholar
  70. 70.
    Pang CY, Behrman HR. Relationship of luteal blood flow and corpus luteum function in pseudopregnant rats. Am J Physiol 1979;237:?30-?4.Google Scholar
  71. 71.
    Pate JL. Involvement of immune cells in regulation of ovarian function. J Reprod Fertil Suppl 1995; 49: 365–77.PubMedGoogle Scholar
  72. 72.
    Juengel JL, Garverick HA, Johnson AL, Youngquist RS, Smith MF. Apoptosis during luteal regression in cattle. Endocrinology 1993; 132: 249–54.PubMedCrossRefGoogle Scholar
  73. 73.
    Rueda BR, Wegner JA, Marion SL, Wahlen DD, Hoyer PB. Intemucleosomal DNA fragmentation in ovine luteal tissue associated with luteolysis: in vivo and in vitro analyses. Biol Reprod 1995; 52: 305–12.PubMedCrossRefGoogle Scholar
  74. 74.
    Rueda BR, Tilly KI, Hansen TR, Hoyer PB, Tilly JL. Expression of superoxide dismutase, catalase and glutathione peroxidase in the bovine corpus luteum: evidence supporting a role for oxidative stress in luteolysis. Endocrine 1995; 3: 227–32.PubMedCrossRefGoogle Scholar
  75. 75.
    Rotello RJ, Lieberman RC, Lepoff RB, Gerschenson LE. Characterization of uterine epithelium apoptotic cell death kinetics and regulation by progesterone and RU486.Am J Path 1992; 140: 449–56.Google Scholar
  76. 76.
    Hopwood D, Levison DA. Atrophy and apoptosis in the cyclical human endometrium. J Pathol 1976; 119: 159–66.PubMedCrossRefGoogle Scholar
  77. 77.
    WelshAO. Uterine cell death during implantation and early placentation. Microsc Res Tech 1993; 25: 223–45.CrossRefGoogle Scholar
  78. 78.
    Walker NI, Bennet RE, Kerr JFR. Cell death by apoptosis during involution of the lactating breast in mice and rats. Am J Anat 1989; 185: 19–32.PubMedCrossRefGoogle Scholar
  79. 79.
    Pesce M, De Filci M. Apoptosis in mouse primordial germ cells: a study by transmission and scanning electron microscope. Anat Embryo 1994; 189: 435–40.CrossRefGoogle Scholar
  80. 80.
    Ratts VS, Flaws JA, Kolp R, Sorenson CM, Tilly JL.Ablation ofbcl-2gene expression decreases the numbers of oocytes and primordial follicles established in the post-natal female mouse gonad. Endocrinology 1995; 136: 3665–8.PubMedCrossRefGoogle Scholar
  81. 81.
    Tilly JL, Kowalski KI, Johnson AL, Hsueh AJW. Involvement of apoptosis in ovarian follicular atresia and postovulatory regression. Endocrinology 1991; 129: 2799–801PubMedCrossRefGoogle Scholar
  82. 82.
    Hughes FM Jr, Gorospe WC. Biochemical identification of apoptosis (programmed cell death) in granulosa cells: evidence for a potential mechanism underlying follicular atresia. Endocrinology 1991; 129: 2415–22.PubMedCrossRefGoogle Scholar
  83. 83.
    Tilly JL, Ratts VS. Biological and clinical importance of ovarian cell death. Contemp Obstet Gynecol 1996; 41: 59–86.Google Scholar
  84. 84.
    Tilly JL. Apoptosis and ovarian function. Rev Reprod 1996; 1: 162–72.PubMedCrossRefGoogle Scholar
  85. 85.
    O’Shea JD, Nightingale MG, Chamley WA. Changes in small blood vessels during cyclical luteal regression in sheep. Biol Reprod 1977; 17: 162–77.PubMedCrossRefGoogle Scholar
  86. 86.
    Dharmarajan AM, Goodman SB, Tilly KI, Tilly JL. Apoptosis during functional corpus luteum regression: evidence of a role for chorionic gonadotropin in promoting luteal cell survival. Endocrine 1994; 2: 295–303.Google Scholar
  87. 87.
    O’Shea JD, McCoy K. Weight, composition, mitosis, cell death and content of progesterone and DNA in the corpus luteum of pregnancy in the ewe. J Reprod Fertil 1988; 83: 107–17.PubMedCrossRefGoogle Scholar
  88. 88.
    Zheng J, Fricke PM, Reynolds LP, Redmer DA. Evaluation of growth, cell, proliferation, and cell death in bovine corpora lutea throughout the estrous cycle. Biol Reprod 1994; 51: 623–32.PubMedCrossRefGoogle Scholar
  89. 89.
    Niswender GD, Reimers TJ, Diekman MA, Nett TM. Blood flow: a mediator of ovarian function. Biol Reprod 1976; 14: 64–81.PubMedCrossRefGoogle Scholar
  90. 90.
    Azmi TI, O’Shea JD. Mechanism of deletion of endothelial cells during regression of the corpus luteum. Lab Invest 1984; 51: 206–17.PubMedGoogle Scholar
  91. 91.
    Braden TD, Gamboni F, Niswender GD. Effects of prostaglandin F2a-induced luteolysis on the populations of cells in the ovine corpus luteum. Biol Reprod 1988; 39: 245–53.PubMedCrossRefGoogle Scholar
  92. 92.
    Flohe L. Glutathione peroxidase brought into focus. In: Pryor WA, ed. Free Radicals in Biology. New York: Academic Press, 1982;5:223–54.Google Scholar
  93. 93.
    Fridovich I. Biological effects of the superoxide radical. Arch Biochem Biophys 1986; 247: 1–11.PubMedCrossRefGoogle Scholar
  94. 94.
    Yu BP. Cellular defenses against damage from reactive oxygen species. Physiol Rev 1994; 74: 139–62.PubMedGoogle Scholar
  95. 95.
    Fridovich I. Superoxide dismutases: defence against endogenous superoxide radical. Ciba Foundation Symposium 1978; 65: 77–93.PubMedGoogle Scholar
  96. 96.
    Blum J, Fridovich I. Inactivation of glutathione peroxidase by superoxide radical. Arch Biochem Biophys 1985; 240: 500–8.PubMedCrossRefGoogle Scholar
  97. 97.
    McConkey DJ, Hartzell P, Nicotera P, Wyllie AH, Orrenius S. Stimulation of endogenous endonuclease in cells exposed to oxidative stress. Toxicol Lett 1989; 42: 123–30.CrossRefGoogle Scholar
  98. 98.
    Wong GHW, Elwell JH, Oberly LW, Goeddel DV. Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell 1989; 58: 923–31.PubMedCrossRefGoogle Scholar
  99. 99.
    Hockenbery DM, Oltvai ZN,Yin XM, Milliman CL, Korsmeyer J. Всl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993; 75: 241–51.Google Scholar
  100. 100.
    Buttke TM, Sandstrom PA. Oxidative stress as a mediator of apoptosis. Immunol Today 1994; 15: 7–10.PubMedCrossRefGoogle Scholar
  101. 101.
    Kerr JFR, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide ranging implications in tissue kinetics. Br J Cancer 1972; 26: 239–57.PubMedCrossRefGoogle Scholar
  102. 102.
    Wyllie АН, Kerr JFR, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol 1980; 68: 251–306.PubMedCrossRefGoogle Scholar
  103. 103.
    Schraufstatter IU, Hyslop PA, Hinshaw DB, Spragg RG, Sklar LA, Cochrane CO. Hydrogen peroxide-induced injury of cells and its prevention by inhibitors of poly (ADP-ribose) polymerase. Proc Nat ’ Acad Sci USA 1986; 83: 490812.Google Scholar
  104. 104.
    Carson DA, Seto S, Wasson DB, Carrera CJ. DNA strand breaks, NAD metabolism and programmed cell death. Exp Cell Res 1986; 164: 273–81.PubMedCrossRefGoogle Scholar
  105. 105.
    Janssen YMW, Van Houten B, Borm PJA, Mossman BT. Biology of disease: cell and tissue responses to oxidative damage. Lab Invest 1993;69:261–74Google Scholar
  106. 106.
    Tilly JL, Tilly KI. Inhibitors of oxidative stress mimic the ability of follicle-stimulating hormone to suppress apoptosis in cultured rat ovarian follicles. Endocrinology 1995; 136: 242–52.PubMedCrossRefGoogle Scholar
  107. 107.
    Gatzuli E, Aten RF, Behrman HR. Inhibition of gonadotropin action and progesterone synthesis by xanthine oxidase in rat luteal cells. Endocrinology 1991; 128: 2253–58.PubMedCrossRefGoogle Scholar
  108. 108.
    Carlson JC, Wu XM, Sawada М. Oxygen radicals and the control of the corpus luteum function. Free Rad Biol Med 1993; 14: 79–84.PubMedCrossRefGoogle Scholar
  109. 109.
    Behrman HR, Aten RF. Evidence that hydrogen peroxide blocks hormone-sensitive cholesterol transport into mitochondria of rat luteal cells. Endocrinology 1991; 128: 2958–66.PubMedCrossRefGoogle Scholar
  110. 110.
    Musicki B, Aten RF, Behrman HR. Inhibition of protein synthesis and hormone-sensitive steroidogenesis in response to hydrogen peroxide in rat luteal cells. Endocrinology 1994; 134: 588–95.PubMedCrossRefGoogle Scholar
  111. 111.
    Sawada M, Carlson JC. Studies on the mechanism controlling generation of superoxide radical in luteinized rat ovaries during regression. Endocrinology 1994; 135: 1645–50.PubMedCrossRefGoogle Scholar
  112. 112.
    Laloraya M, Pradeep KG, Laloraya MM. Changes in the levels of superoxide anion radical and superoxide dismutase during the estrous cycle of Rattus norvegicusand induction of superoxide dismutase in the rat ovary by lutropin. Biochem Biophys Res Commun 1988; 157: 146–53.PubMedCrossRefGoogle Scholar
  113. 113.
    Sawada M, Carlson JC. Superoxide radical production in plasma membrane samples from regressing rat corpora lutea. Can J Physiol Pharmacol 1989; 67: 465–71.PubMedCrossRefGoogle Scholar
  114. 114.
    Sawada M, Carlson JC. Rapid plasma membrane changes in superoxide radical formation, fluidity, and phospholipase A2 activity in the corpus luteum of the rat during induction of luteolysis. Endocrinology 1991; 128: 2992–98.PubMedCrossRefGoogle Scholar
  115. 115.
    Sugino N, Shimamura K, Tamura H, Ono M, Nakamura Y, Ogino K, Kato H. Progesterone inhibits superoxide radical production by mononuclear phagocytes in pseudopregnant rats. Endocrinology 1996; 137: 749.PubMedCrossRefGoogle Scholar
  116. 116.
    Vega M, Castillo M, Retamales I, Las Heras J, Devoto L, Videla LA. Steroidogenic capacity and oxidative stress-related parameters in human luteal cell regression. Free Rad Biol Med 1994; 17: 493.PubMedCrossRefGoogle Scholar
  117. 117.
    Murdoch WJ. Treatment of sheep with prostaglandin F2alphaenhances production of a luteal chemoattractant for eosinophils. Am J Reprod Immunol Micro 1987; 15: 52–56.Google Scholar
  118. 118.
    McPherson LA, VanKirk EA, Murdoch WJ. Localization of stress protein-70 in ovine corpora lutea during prostaglandin-induced luteolysis. Prostaglandins 1993; 46: 433–40.PubMedCrossRefGoogle Scholar
  119. 119.
    Khanna A, Aten RF, Behrman HR. Heat shock protein induction blocks hormone-sensitive steroidogenesis in rat luteal cells. Steroids 1994; 59: 4–7.PubMedCrossRefGoogle Scholar
  120. 120.
    TsujimotoY, Cossman J, Jaffe E, Croce CM. Involvement of thebcl-2gene in human follicular lymphoma. Science 1985; 228: 1440–43.CrossRefGoogle Scholar
  121. 121.
    Bakhshi A, Jensen JP, Goldman P, Wright JJ, McBride OW, Epstein AL, Korsmeyer SJ. Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on chromosome 18. Cell 1985; 41: 899–906.PubMedCrossRefGoogle Scholar
  122. 122.
    Cleary ML, Sklar J. Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18. Proc Nat ’ Acad Sci USA 1985; 82; 74309.CrossRefGoogle Scholar
  123. 123.
    Vaux DL, Weissman IL, Kim SL. Prevention of programmed cell death in Caenorhabditis elegansby human Ьсl-2. Science 1992; 258: 1955–7.PubMedCrossRefGoogle Scholar
  124. 124.
    Vaux DL, Cory S, Adams JM. bel-2gene promotes haemopoietic cell survival and cooperates with c-mycto immortalize pre-B cells. Nature 1988; 335: 440–2.PubMedCrossRefGoogle Scholar
  125. 125.
    Nunez G, London L, Hockenberry D, Alexander M, McKern JP, Korsmeyer SJ. Deregulated bc1–2gene expression selectively prolongs survival of growth factor-deprived hematopoietic cell lines. J Inununol 1990; 144: 3602–10.Google Scholar
  126. 126.
    Reed JC. Bcl-2 and the regulation of programmed cell death. J Cell Biol 1994; 124: 1–6.PubMedCrossRefGoogle Scholar
  127. 127.
    Hockenbery DM, Nunez G, Millman CL, Schreiber RD, Korsmeyer J. Всl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990; 348: 334–36.PubMedCrossRefGoogle Scholar
  128. 128.
    Chen-Levy Z, Nourse J, Cleary ML. The Bсl-2 candidate proto-oncogene product is a 24-kilodalton integral-membrane protein highly expressed in lymphoid cell lines and lymphomas carrying the t(14;18). Mol Cell Biol 1989: 9: 701–10.PubMedGoogle Scholar
  129. 129.
    Jacobson MD, Burne JF, King MP, Miyashita T, Reed JC, Raff MC. 1993 Bс1–2 blocks apoptosis in cells lacking mitochondrial DNA. Nature 1993; 361: 365–9.PubMedCrossRefGoogle Scholar
  130. 130.
    Monaghan P, Robertson D, Amos TAS, Dyer MJS, Mason DY, Greaves MF. Ultrastructural localization of Всl-2 protein. J Histochem Cytochem 1992; 40: 1819–25.PubMedCrossRefGoogle Scholar
  131. 131.
    Hockenbery DM, Oltavi ZN, Yin X-M, Milliman CL, Korsmeyer SJ. Bсl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993; 75: 241–51.PubMedCrossRefGoogle Scholar
  132. 132.
    Kane DJ, Sarafian TA, Anton R, Hajn H, Gralla EB, Valentine JS, Ord T, Bredesen DE. Bcl-inhibition of neural death: decreased generation of reactive oxygen species. Science 1993; 262: 1274–78PubMedCrossRefGoogle Scholar
  133. 133.
    Korsmeyer SJ. Regulators of cell death. Trends Gene 1995; 11: 101–5.CrossRefGoogle Scholar
  134. 134.
    Oltvai ZN, Milliman CL, Korsmeyer SJ;. Всl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993; 74: 609–19.PubMedCrossRefGoogle Scholar
  135. 135.
    Korsmeyer SJ, Yin X-M, Oltvai ZN, Veis-Novack DJ, Linette GP. Reactive oxygen species and the regulation of cell death by the bсl-2 gene family. Bichim Biophys Acta 1995; 1271: 63–66.CrossRefGoogle Scholar
  136. 136.
    Boise LH, Gonzalez-Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G, Thompson CB. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 1993; 74: 597–608.PubMedCrossRefGoogle Scholar
  137. 137.
    Yin X-M, Oltvai ZN, Korsmeyer SJ. BH 1 and ВН2 domains of Всl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature 1994; 369: 321–3.PubMedCrossRefGoogle Scholar
  138. 138.
    Tilly KI, Banerjee S, Banerjee PP, Tilly JL. Expression of the p53 and Wilm’s tumor suppressor genes in the rat ovary: gonadotropin repression in vivo and immunohistochemical localization of nuclear p53 protein to apoptotic granulosa cells of atretic follicles. Endocrinology 1995; 136: 1394–402.PubMedCrossRefGoogle Scholar
  139. 139.
    Mercer WE, Sheieds MT, Amin M, Sauve GJ, Appella E, Romano JW, Ullrich SJ. Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53. Proc Natl Acad Sci USA 1990; 87: 6166–70.PubMedCrossRefGoogle Scholar
  140. 140.
    Martin SJ, Green DR, Cotter TG. Dicing with death: dissecting the components of the apoptosis machinery. TIES 1994; 19: 26–30.Google Scholar
  141. 141.
    Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A, Oren M. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 1991; 352: 345–7.PubMedCrossRefGoogle Scholar
  142. 142.
    Fritsche M, Haessler C, Brander G. Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents. Oncogene 1993; 8: 307–18.PubMedGoogle Scholar
  143. 143.
    Hollestein M, Sidransky D, Vogelstein B, Harris C. p53 mutations in human cancers. Science 1991; 253: 49–53.CrossRefGoogle Scholar
  144. 144.
    Vogelstein B, Kinzler KW. p53 function and dysfunction. Cell 1992; 70: 523–6.PubMedCrossRefGoogle Scholar
  145. 145.
    Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human baxgene. Cell 1995; 80: 293–9.PubMedCrossRefGoogle Scholar
  146. 146.
    Miyashita T, Harigai M, Hanada M, Reed JC. Identification of a p53-dependent negative response element in the bc1–2 gene. Cancer Res 1994; 54: 3131–5.PubMedGoogle Scholar
  147. 147.
    Tilly JL, Tilly KI, Kenton ML, Johnson AL. Expression of members of the bdl-gene family in the immature rat ovary: equine chorionic gonadotropin-mediated inhibition of apoptosis is associated with decreased baxand constitutive bcl-and bcl-x LONGmessenger ribonucleic acid levels. Endocrinology 1995; 136: 232–41.PubMedCrossRefGoogle Scholar
  148. 148.
    Knudson CM, Tung KSK, Tourtellotte WG, Brown GAJ, Korsmeyer SJ. Baxdeficient mice with lymphoid hyperplasia and male germ cell death. Science 1995; 270: 96–9.PubMedCrossRefGoogle Scholar
  149. 149.
    Tilly JL. The molecular basis of ovarian cell death during germ cell attrition, follicular atresia, and luteolysis. Frontiers in Bioscience 1996; 1: 1–10.Google Scholar
  150. 150.
    Leighr DR, Gentry PC, Smith GW, Smith MF. Cloning and initial characterization of ovine Всl-2 expression by corpora lutea. Biol Reprod 1995; 52 (Suppl 1): 44.Google Scholar
  151. 151.
    Rodger FE, Fraser HM, Duncan WC, Illingworth PJ. Immunolocalization of Всl-2 in the human corpus luteum. Mol Human Repr 1995; 10: 1566–70.CrossRefGoogle Scholar
  152. 152.
    Rueda BR, Tilly KI, Botros I, Jolly PD, Hansen TR, Hoyer PB, Tilly JL. Increased baxand interleukin-1 β-converting enzyme (Ice)messenger RNA levels coincide with apoptosis in the bovine corpus luteum during structural regression. Biol Reprod 1997; 56: 186–93.PubMedCrossRefGoogle Scholar
  153. 153.
    Kastan MB, Onyekwere O, Sidransky D, Volgelstein B, Craig RW. Participation of p53 protein in the cellular response to DNA damage. Cancer Res 1991; 51: 6304–11.PubMedGoogle Scholar
  154. 154.
    Keren-Tal I, Suh B-S, Dantes A, Lindner S, Oren М, Amsterdam A. Involvement of p53 expression in cAMP-mediated apoptosis in immortalized granulosa cells. Exp Cell Res 1995; 218: 283–95.PubMedCrossRefGoogle Scholar
  155. 155.
    Martin SJ, Green DR. Protease activation during apoptosis: death by a thousand cuts? Cell 1995; 82: 349–52.PubMedCrossRefGoogle Scholar
  156. 156.
    Yaun J, Shaham S, Ledoux S, Ellis HM, Horvitz HR. The C. elegansdeath gene ced-3 encodes a protein similar to mammalian interleukin-lβ-converting enzyme. Cell 1993; 75: 653–60.CrossRefGoogle Scholar
  157. 157.
    Hengartner MO, Horvitz HR. C. elegans survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2. Cell 1 994;76:655–76.Google Scholar
  158. 158.
    Yaun J, Horvitz HR. Genetic and mosaic analysis of ced-3and ced-4, two genes that control programmed cell death in the nematode, C. elegans. Dev Biol 1990; 138: 33–41.CrossRefGoogle Scholar
  159. 159.
    Black RA, Kronheim SR, Sleath PR. Activation of interleukin-1β by a coinduced protease. FEES Lett 1989; 247: 386–90.CrossRefGoogle Scholar
  160. 160.
    Miura M, Zhu H, Rotello R, Hartweig EA, Yaun J. Induction of apoptosis in fibroblasts by IL-1β-converting enzyme, a mammalian homolog of the C. eleganscell death gene ced-3. Cell 1993; 75: 653–60.PubMedCrossRefGoogle Scholar
  161. 161.
    Ray CA, Black RA, Kronheim SR, Greenstreet TA, Sleath PR, Salvesen GS, Pickup DJ. Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin-1 ‚3-converting enzyme. Cell 1992; 69: 597–604.PubMedCrossRefGoogle Scholar
  162. 162.
    Enari М, Hug H, Nagata S. Involvement of an ICE-like protease in FAS-mediated apoptosis. Nature. 1995; 375: 78–81.PubMedCrossRefGoogle Scholar
  163. 163.
    Tewari M, Dixit VM. Fas-and tumor necrosis factor-induced apoptosis is inhibitied by the poxvirus crmA gene product. J Biol Chem 1995; 270: 3255–60.PubMedCrossRefGoogle Scholar
  164. 164.
    Li P, Allen H, Banerjeee S, Franklin S, Herzog L, Johnston C, McDowell J, Paskind M, Rodman L, Salfield J, Towne E, Tracy D, Wardwell S, Wei F-Y, Wong W, Kamen R, Seshadri Т. Mice deficient in IL-1P-converting enzyme are defective in production of mature IL-1β and resistent to endotoxic shock. Cell 1995; 80: 401–11.PubMedCrossRefGoogle Scholar
  165. 165.
    Kumar S, TomookaY, Noda M. Identification of a set of genes with developmentally down-regulated expression in the mouse brain. Biochem Biophys Res Commun 1992; 185: 1155–61.PubMedCrossRefGoogle Scholar
  166. 166.
    Wang L, Miura M, Bergeron L, Zhu H, Yaun J. Ich-1, an ICE/ced-3-related gene, encodes both positive and negative regulators of programmed cell death. Cell 1994; 78: 739–50.PubMedCrossRefGoogle Scholar
  167. 167.
    Fernandes-Alnemri T, Litwack G. Alnemri ES. CPP32, a novel human protein with homology to Caenorhabditis eleganscell death protein CED-3 and the mammalian interleukin-lß-converting enzyme. J Biol Chem 1994; 269: 30761–4.PubMedGoogle Scholar
  168. 168.
    Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding СК, Gallant M, et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 1995; 376: 37–43.PubMedCrossRefGoogle Scholar
  169. 169.
    Tewari M, Quan LT, O’Rourke K, Desnoyers S, Zeng Z, Seidler DR, Poirier GG, Salverson GS, Dixit VM. Yama/CPP32ß, a mammalian homolog of CED-3, is a crmA-inhibitab e protease that cleaves the death substrate poly (ADP-ribose) polymerase. Cell 1995; 81: 801–9.PubMedCrossRefGoogle Scholar
  170. 170.
    Lazebnik YA, Kaufman SH, Desnoyers S, Poirer GG, Earnshaw WC. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 1994; 371: 346–7.PubMedCrossRefGoogle Scholar
  171. 171.
    Flaws JA, Kugu K, Trbovich AM, DeSanti A, Tilly KI, Hirshfield AN, Tilly JL. Interleukin-1 ß-converting enzyme-related proteases (IRPs) and mammalian cell death: dissociation of IRP-induced oligonucleosomal endonuclease activity from morphological apoptosis in granulosa cells of the ovarian follicle. Endocrinology 1995; 136: 5042–53.PubMedCrossRefGoogle Scholar
  172. 172.
    Maravei DV, Trbovich AM, Perez GI, Tilly KI, Talanian RV, Banach D,Wong WW, Tilly JL. Cleavage of cytoskeletal proteins by caspases during ovarian cell death: evidence that cell-free systems do no always mimic apoptotic events in intact cells. Cell Death Differen 1997;4(in press).Google Scholar
  173. 173.
    Chinnaiyan AM, Orth K, O’Rourke K, Duan H, Poirier GG, Dixit VM. Molecular ordering of the cell death pathway. Bcl-2 and Bc1-XL function upstream of the CED-3-like apoptotic proteases. J Biol Chem 1996; 271: 4573–84.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1997

Authors and Affiliations

  • Bo R. Rueda
  • Debora L. Hamernik
  • Patricia B. Hoyer
  • Jonathan L. Tilly

There are no affiliations available

Personalised recommendations